Editor-in-Chief:

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE Cedex 20
FRANCE

Section Editor:

T.A. Black (Infec. Dis. Drug Discov, Merck Res. Lab. Kenilworth, NJ, USA)
L.E. Hensley (US Army Medical Research Institute of Infectious Diseases, Maryland, USA)
W.M. Kazmierski (GlaxoSmithKline Res. & Develop., NC, USA)
E. Loret (Lab. Retrovirology, Faculté de Pharmacie, Marseille Cedex 5, France)
T.R. Tong (Dep. Path. Montefiori Med. Center North Div., Bronx, NY, USA)

Editorial Advisory Board:

C. Abad-Zapatero (Abbott Lab., Abbott Park, IL, USA)
A.K. Agrawal (PolyMASC Pharm Plc., London)
D. Andreotti (GlaxoSmithkline Res. Centre, Verona, Italy)
J.L. Blanchard (University Massachusetts, Amherst, MA, USA)
A. Branstrom (PTC Therapeutics, South Plainfield, NJ, USA)
Y. Cheng (Yale University, New Haven, CT, USA)
P. Clapham (University of Massachusetts Medical School, Worcester, USA)
P.M. Colman (The Walter and Eliza Hall Inst., Melbourne, Victoria, Australia)
P. Courvalin (Institute Pasteur, Paris, France)
H.L. Davis (Coley Pharm. Group, Ottawa, ON, Ontario, Canada)
E.De Clercq (Rega Institute, K.U. Leuven, Belgium)
F. Doucet-Populaire (University of Paris, Paris, France)
B.M. Dunn (University of Florida College of Medicine, Florida, USA)
B. Finlay (University British Colombia, Vancouver, BC, Canada)
R. Gallo (University of Maryland in Baltimore, Maryland, USA)
O. Golubnitschaja (Friedrich-Wilhelms, University of Bonn, Germany)
G. Gregoriadis (University London, London, UK)
S. Ilyin (Johnson & Johnson Pharm Res and Dev., Spring House, PA, USA)
Kuan-T. Jeang (Nat. Institute Health, Bethesda, MD, USA)
D. Kahne (Harvard University, Boston, MA, NJ, USA)
S. Lory (Harvard University, Boston, MA, USA)
B.C. Monk (University Otago, Dunedin, New Zealand)
B.E. Murray (University of Texas, Houston, TX, USA)
R.N. Ondarza (Nat. Institute Public Health, Mexico)
M.C. O'Sullivan (Canisius College, Buffulo, NY, USA)
J. Pace (Protez Pharmaceuticals, Melvern, PA, USA)
F. Scaglione (University of Milan, Milan, Italy)
M.E. Selsted (Keck School of Medicine of USC , Los Angeles, USA)
I. Shinkai (Mitsui & Co. Ltd., Tokyo, JAPAN)
M.J. Sofia (Pharmasset, Incorporation, Princeton, NJ, USA)
G.G. Stone( Pfizer Global Research and Development, Groton, USA)
Babu L. Tekwani ( National Center for Natural Products Research, University of Mississippi, USA)
T.J. Trust (AstraZeneca, Waltham, MA, USA)
M. Wainberg (McGill AIDS Centre, Jewish General Hospital, Montreal ,Canada)
T. Wood (Pfizer Global Research and Development, Kent, UK)
ZHANG Xiao-Lian (Department of Immunology, Wuhan University, China)